Has Omar Qutub received payments from drug or device companies?

Yes. Drug and device makers reported $107,355 in general payments to Omar Qutub across 241 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Omar Qutub did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Omar Qutub come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Omar Qutub

Dermatology · Portland, ORNPI 1124280540

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $73,379 of the $107,355 with a category attached, or 68.4%. Johnson & Johnson accounts for 89.6% of it on its own, with 22 other manufacturers making up the rest. Among dermatology clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$107,355in general payments, 2019–2025

Across 241 payments — averaging $445.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$96K
Pfizer$7K
Arcutis Biotherapeutics, Inc.$1K
AbbVie$682
Galderma Laboratories, L.p.$304
Amgen$283
plus $2K from 17 others

What the payments were for

Consulting fees$13,65513%
Speaking & faculty fees$73,37968%
Travel & lodging$12,90212%
Food & beverage$7,1107%
Education$3090%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	127	$96,142
Pfizer	11	$6,990
Arcutis Biotherapeutics, Inc.	8	$1,359
AbbVie(2 entities)	26	$682
Galderma Laboratories, L.p.	10	$304
Amgen	19	$283
E.r. Squibb & Sons, L.L.C.	7	$232
Ortho Dermatologics, A Division Of Bausch Health US, LLC	2	$171
Almirall LLC	2	$150
Sun Pharmaceutical Industries Inc.	4	$148
Janssen Scientific Affairs, LLC	4	$139
Incyte Corporation	2	$130
Dermavant Sciences, Inc.	1	$102
Regeneron Healthcare Solutions, Inc.	3	$95
Journey Medical Corporation	1	$90
Sanofi	3	$87
Lilly USA, LLC	3	$69
Stemline Therapeutics Inc.	1	$58
Medtronic	1	$32
UCB, Inc.	1	$25
Novartis	1	$24
Strata Skin Sciences, Inc.	3	$22
Merz North America, Inc.	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Tremfya$94,258
INFLECTRA$6,710
ZORYVE$1,100
BOTOX$126
NEMLUVIO$125
OPZELURA$109
VTAMA$102
ALTRENO$100

How this compares

$107,355 in reported general payments places this provider in the 95th percentile of 175 dermatology providers in Oregon.

See all dermatology providers in Oregon →

Other dermatology in Portland

Andrew BlauveltPortland$1.8M
Benjamin EhstPortland$1.5M
Jason HawkesPortland$1.5M
Eric SimpsonPortland$1.4M
Alex Ortega LoayzaPortland$122K
Paul HaunPortland$85K
Kathryn SchwarzenbergerPortland$34K
Jon HanifinPortland$25K
Phoebe RichPortland$17K
Tracy FunkPortland$16K

See the full list for Oregon →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →